Acorda COO to step down
<p>Shares of <strong>Acorda Therapeutics, Inc.</strong> (Nasdaq: <a href="/quotes?symbol=acor">ACOR</a>) edged lowering in pre-market trading this morning after Acorda’s Chief Operating Officer, Mary Fisher, said she is resigning to pursue other interests </p> <p>Acorda is a biotechnology company that develops therapies for SCI, MS and related nervous system disorders.</p> <p>Shares of Acorda edged down 0.86%, or $0.18, to $20.83 in pre-market trading. <br /> </p>
